<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04170764</url>
  </required_header>
  <id_info>
    <org_study_id>19-111</org_study_id>
    <nct_id>NCT04170764</nct_id>
  </id_info>
  <brief_title>Clinical Utility of Postoperative Hemoglobin Testing</brief_title>
  <official_title>Clinical Utility of Postoperative Hemoglobin Testing Following Vaginal Hysterectomy and Reconstruction for Symptomatic Pelvic Organ Prolapse</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TriHealth Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TriHealth Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate how many patients have hemoglobin less than 10 g/dL
      at post-operative day 1.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obtaining a complete blood count (CBC) on post-operative day 1 to assess postoperative
      hemoglobin levels is routine practice at Cincinnati Urogynecology Associates, TriHealth Inc.
      after pelvic reconstructive surgery.

      There is minimal data supporting this practice. Multiple studies throughout the gynecology
      literature suggest that this is not a necessary or cost effective strategy to assess for
      postoperative anemia. Most patients who require blood transfusion or reoperation for bleeding
      will show clinical signs of anemia.

      The investigators aim to determine if checking a routine CBC results in clinically relevant
      changes to patient care in women undergoing pelvic reconstructive surgery with vaginal
      hysterectomy for treatment of pelvic organ prolapse.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 22, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of subjects with hemoglobin less than 10 g/dL</measure>
    <time_frame>Postop Day 1</time_frame>
    <description>Number of subjects with hemoglobin less than 10 g/dL following Vaginal Hysterectomy and Reconstruction for Symptomatic Pelvic Organ Prolapse</description>
  </primary_outcome>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Anaemia Postoperative</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who underwent a total vaginal hysterectomy with concurrent vaginal native
        tissue prolapse repairs performed by one of four fellowship trained urogynecologists at
        TriHealth between 10/1/2014 and 10/1/2019. The patients will be identified by CPT codes in
        the EPIC electronic medical record.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Total vaginal hysterectomy with or without bilateral salpingectomy/oophorectomy (CPT
             58260, 58262, 58263, 58270, 58290, 58291, 58292, 58294)

          -  At least one of the following vaginal native tissue prolapse repairs

               -  Apical repair with uterosacral ligament suspension (CPT 57283)

               -  Apical repair with sacrospinous ligament fixation (CPT 57282)

               -  Anterior repair (CPT 57240, 57260, 57284, 57285, 57250)

               -  Posterior repair (CPT 45560, 56800, 56810, 57200, 57210, 57250)

          -  Surgery by one of four fellowship trained urogynecologists at TriHealth

        Exclusion Criteria:

          -  Concomitant surgical procedure by a second surgeon

          -  Malignancy identified at the time of surgery or active malignancy

          -  Cases converted to open hysterectomy or prolapse repairs

          -  Prolapse repair completed robotically

          -  Prolapse repair completed with mesh

          -  Known coagulopathy

          -  Patient on long term preoperative anticoagulant medication (Arixtra, Coumadin,
             Eliquis, Heparin, Lovenox, Pradaxa, Savaysa, Xarelto)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rachel Pauls, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>TriHealth - Cincinnati Urogynecology Associates</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eunsun Yook, MS</last_name>
    <phone>513-463-4300</phone>
    <email>eunsun_yook@trihealth.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emily Aldrich, MD</last_name>
    <phone>513-463-4300</phone>
    <email>Emily_Aldrich@trihealth.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cincinnati Urogynecology Associates</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vivian Ghodsi, RN</last_name>
      <phone>513-463-4300</phone>
      <email>vivian_ghodsi@trihealth.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>November 18, 2019</study_first_submitted>
  <study_first_submitted_qc>November 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2019</study_first_posted>
  <last_update_submitted>February 4, 2020</last_update_submitted>
  <last_update_submitted_qc>February 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

